Human haemoglobin (Sangart)

N/A

Report date: 2022/01/14 13:23:58

Base Information

Drug NameHuman haemoglobin (Sangart)

Drug Alias NamePegylated haemoglobin-based colloid - SangartOxygenated polyethylene glycol-modified haemoglobinMP4OX (oxygencarrying colloid and plasma expander)HemospanMalPEG-Hb +[7]

ClassificationBiologics > Blood components

Mechanisms of ActionOxygen carriers

TargetsNot applicable

Therapy Area/IndicationsIschemia

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryN/A

CombinationsNo

Global Highest StatusPending (Phase 3 Clinical)

Highest Status in ChinaN/A

Originator CompaniesSangart Inc

China Registration ClassN/A

Develop Information

Active CompaniesN/A

Inactive CompaniesSangart Inc

Active IndicationsN/A

Inactive IndicationsIschemia

Other Information

ATC CodeN/A